Academic Journal
View in EDS
Linked Full Text

Mindfulness meditation for pulmonary hypertension program development: Acceptability and feasibility of technology-assisted complementary health intervention for symptom self-management.

Bibliographic Details
Title: Mindfulness meditation for pulmonary hypertension program development: Acceptability and feasibility of technology-assisted complementary health intervention for symptom self-management.
Authors: Von Visger TT; Assistant Professor, The Medical University of South Carolina, College of Nursing, Charleston, SC, USA. Electronic address: vonvisge@musc.edu., Chang YP; Associate Dean for Research and Scholarship, Associate Professor, School of Nursing, The State University of New York, University at Buffalo, Buffalo, NY, USA.
Source: Heart & lung : the journal of critical care [Heart Lung] 2026 Jul-Aug; Vol. 78, pp. 102759. Date of Electronic Publication: 2026 Mar 12.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Language: English
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0330057 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3288 (Electronic) Linking ISSN: 01479563 NLM ISO Abbreviation: Heart Lung Subsets: MEDLINE
Imprint Name(s): Original Publication: St. Louis, Mosby.
MeSH Terms: Hypertension, Pulmonary*/therapy , Hypertension, Pulmonary*/psychology , Mindfulness*/methods , Meditation*/methods , Self-Management*/methods , Quality of Life* , Program Development*, Humans ; Female ; Male ; Middle Aged ; Feasibility Studies ; Adult ; Aged ; Patient Acceptance of Health Care ; Mobile Applications ; Pilot Projects ; Digital Health
Abstract: Background: Adults with pulmonary hypertension (PH) live with a high symptom burden, psychological distress, and poor quality of life. Mindfulness-based interventions delivered in person or virtually have shown clinical benefits for chronic conditions and PH. Pilot testing of the Mindfulness Meditation for Pulmonary Hypertension (MMPH), an 8-week, web-based, multimodal program, shows improvement in depression, symptoms, and quality of life.
Objectives: To evaluate the MMPH program's acceptability and feasibility quantitatively and qualitatively from MMPH participants.
Methods: Descriptive statistics were used to report adherence to and completion of each component of MMPH (Zoom, video, and app use) among 15 participants who received the intervention in 2022-2023. Qualitative thematic analysis was conducted on their daily reflection journals, downloaded from the MMPH app.
Results: Fifteen participants attended 28 out of 30 Zoom sessions (93%). Twelve of 15 (80%) participants accessed the video-viewing activity at least 50% of the time (3 of 6 videos). Eight out of 15 participants (53%) used the App during the intervention period, and 6 out of 15 participants (40%) used the App for >2 weeks. The content analysis reveals four most salient themes: Perceived Benefits of Meditation, Daily Life Practice and Activity, Awareness and Acceptance, and PH Symptom Improvement. The System Usability Scale for the MMPH program was 81.47 (±10.21), indicating moderate acceptability.
Conclusions: Assessing the feasibility and acceptability of a complex behavioral health intervention, such as the MMPH program, is critical to ensuring consistent intervention fidelity. Comprehensive approaches are essential to guide necessary program modifications for future real-world implementation science testing.
(Copyright © 2026 The Authors. Published by Elsevier Inc. All rights reserved.)
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References: West J Nurs Res. 2021 Aug;43(8):723-731. (PMID: 33246388)
Complement Ther Med. 2023 Nov;78:102977. (PMID: 37625624)
Pilot Feasibility Stud. 2018 May 21;4:78. (PMID: 29796292)
Complement Ther Med. 2019 Aug;45:45-49. (PMID: 31331581)
J Pain Symptom Manage. 2019 Apr;57(4):802-808. (PMID: 30684635)
Mindfulness (N Y). 2019 Feb;10(2):215-233. (PMID: 30854147)
J Consult Clin Psychol. 2010 Apr;78(2):169-83. (PMID: 20350028)
Mindfulness (N Y). 2018;9(4):1191-1205. (PMID: 30100934)
J Palliat Med. 2020 May;23(5):703-711. (PMID: 31644380)
Ann Epidemiol. 2022 Nov;75:47-52. (PMID: 36089225)
Respir Care. 2021 Jun;66(6):960-971. (PMID: 33906954)
Health Psychol. 2004 Sep;23(5):443-51. (PMID: 15367063)
MMWR Morb Mortal Wkly Rep. 2023 Nov 17;72(46):1250-1256. (PMID: 37971940)
J Telemed Telecare. 2019 Sep;25(8):468-475. (PMID: 29940797)
Mult Scler. 2022 Aug;28(9):1392-1401. (PMID: 35130768)
Int J Environ Res Public Health. 2023 Apr 14;20(8):. (PMID: 37107796)
Biomed Environ Sci. 2023 Apr 20;36(4):353-366. (PMID: 37105910)
Pulm Circ. 2021 Jan 7;11(1):2045894020977300. (PMID: 33456755)
Pulm Circ. 2022 Jan 18;12(1):e12020. (PMID: 35506069)
J Thorac Dis. 2023 Jun 30;15(6):3256-3272. (PMID: 37426148)
Disabil Rehabil. 2024 Jun;46(12):2496-2511. (PMID: 37480272)
J Card Fail. 2025 Apr;31(4):725-729. (PMID: 39461712)
Ann N Y Acad Sci. 2019 Jun;1445(1):5-16. (PMID: 30575050)
Physiother Theory Pract. 2022 Jul;38(7):847-857. (PMID: 32808571)
J Med Internet Res. 2024 Feb 20;26:e48557. (PMID: 38376899)
J Bodyw Mov Ther. 2018 Oct;22(4):896-903. (PMID: 30368332)
J Sch Psychol. 2021 Feb;84:1-18. (PMID: 33581765)
Beni Suef Univ J Basic Appl Sci. 2023;12(1):50. (PMID: 37251428)
Arch Gen Psychiatry. 2006 May;63(5):484-9. (PMID: 16651505)
Cardiol Clin. 2016 Aug;34(3):443-9. (PMID: 27443140)
Vascul Pharmacol. 2023 Aug;151:107180. (PMID: 37178949)
BMC Health Serv Res. 2017 Jan 26;17(1):88. (PMID: 28126032)
J Med Internet Res. 2015 Jan 19;17(1):e8. (PMID: 25599904)
Heart Lung. 2018 Mar - Apr;47(2):115-121. (PMID: 29361341)
Eur Respir J. 2023 Jan 6;61(1):. (PMID: 36028254)
J Pain Symptom Manage. 2016 Jan;51(1):25-32. (PMID: 26300023)
Cancer Med. 2017 May;6(5):1108-1122. (PMID: 28421677)
Nurs Res. 2021 Mar-Apr 01;70(2):150-161. (PMID: 33630538)
J Pain Symptom Manage. 2017 Jan;53(1):85-95. (PMID: 27720794)
J Med Internet Res. 2017 Aug 31;19(8):e303. (PMID: 28860106)
Pulm Circ. 2025 Aug 20;15(3):e70154. (PMID: 40843463)
J Clin Oncol. 2021 Nov 1;39(31):3473-3484. (PMID: 34406839)
Grant Information: UL1 TR001412 United States TR NCATS NIH HHS
Contributed Indexing: Keywords: Acceptability; Complementary health approach (CHA); Feasibility; Intervention fidelity monitoring (IFM); Meditation; Mindfulness; Mindfulness mobile app; Pulmonary hypertension (PH)
Entry Date(s): Date Created: 20260313 Date Completed: 20260617 Latest Revision: 20260910
Update Code: 20260911
PubMed Central ID: PMC13340582
DOI: 10.1016/j.hrtlng.2026.102759
PMID: 41825305
Database: MEDLINE
Description
ISSN:1527-3288
DOI:10.1016/j.hrtlng.2026.102759